Actinium Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative targeted payload immunotherapeutics. With a pipeline of Antibody Radiation Conjugates, Actinium aims to provide targeted conditioning and combination therapies for patients with unmet medical needs. The company has been awarded grants by the National Institutes of Health and has garnered a significant following of over 10,000 followers on LinkedIn. Actinium Pharmaceuticals is listed on the NYSE MKT under the ticker symbol ATNM.

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Awarded Grant by National Institutes of Health to Study Novel Iomab-ACT Targeted Conditioning with a CD19 CAR T-Cell ...

Actinium Pharmaceuticals, Inc. | 10527 followers on LinkedIn. Targeted Therapies for Patients with Unmet Needs | Actinium Pharmaceuticals ...

Actinium Pharmaceuticals, Inc.

Find contacts at this company